|Table of Contents|

The relationship between MSCT features and HER-2 expression in gastric cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 06
Page:
908-910
Research Field:
Publishing date:

Info

Title:
The relationship between MSCT features and HER-2 expression in gastric cancer
Author(s):
Cai Miaotian; Meng Wei; Jiang Zhiyun; Zhang Xiushi
Imaging Center,Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150081,China.
Keywords:
epidermal growth factor receptor 2; MSCT; gastric cancer
PACS:
R735.2
DOI:
10.3969/j.issn.1672-4992.2018.06.022
Abstract:
Objective:To investigate the relationship between MSCT sign and HER-2 expression in gastric cancer.Methods:We retrospectively analyzed the MSCT scan data of 117 patients with gastric cancer in Harbin Medical University Cancer Hospital.The size,thickness,location,enriched the way and the degree of tumor,invasion depth,Borrmann type and lymph node metastasis were measured or judged respectively.In all patients the expression of HER-2 was detected by immunohistochemistry.The relationship between MSCT imaging and HER-2 expression was analyzed by statistical method.Results:There were 23 cases(19.7%) HER-2 over expression in 117 cases,and the relationship between HER-2 overexpression and tumor size,enriched the degree of tumor and lymph node metastasis was statistically significant(P＜0.05).However,There was no statistically significant difference between HER-2 overexpression and tumor thickness,location,enriched the way of tumor,invasion depth,borrmann type(P＞0.05).Conclusion:The size of tumor,the degree of enhancement and the lymph node metastasis of MSCT in gastric cancer can reflect HER-2 expression to a certain extent,and it have a potential clinical application value.

References:

[1]Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:Sources,methods and major patterns in GLOBOCAN 2012［J］.Int J Cancer,2015,136(5):359-386.
[2]Cervantes A,Rosello S,Roda D,et al.The treatment of advanced gastric cancer:Current strategies and future perspectives［J］.Ann Oncol,2008,19(suppl 5):103-107.
[3]Movagharnejad K,Sharbatdaran M,Sheffaee S,et al.HER-2/neu marker examination using immunohistochemi-cal method in patients suffering from gastric adenocarcinoma［J］.Int J Mol Cell Med,2013,2(4):199-203.
[4]Ma Shaojun,Liu Yanmei,Zhang Yuelang,et al.The relationship of imaging and clinicopathologic feature of tumors with human epidermal growth factor receptor type 2 overexpression in estrogen receptor-negative breast carcinomas［J］.Modern Oncology,2016,24(23):3725-3729.［马少君，刘延梅，张月浪，等.雌激素受体阴性乳腺癌 HER-2 过表达及与影像学和临床病理特征的关系［J］.现代肿瘤医学，2016,24(23):3725-3729.］
[5]Bang YJ,Van CE,Feyereislova A,et al.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA):A phase 3,open-label,randomised controlled trial［J］.Lancet,2010,376(9742):687-697.
[6]Y1ld1z Y,Sokmensuer C,Yalcin S.Evaluation of c-Met,HGF,and HER-2 expressions in gastric carcinoma and their association with other clinicopathological factors［J］.Onco Targets and Therapy,2016,9:5809-5817
[7]Yan B,Yau EX,Bte OSS,et al.A study of HER2 gene amplification and protein expression in gastric cancer［J］.Clin Pathol,2010,63(9):839-842.
[8]Liang JW,Zhang JW,Zhang JJ,et al.Clinicopathological and prognostic significance of HER2 overexpression in gastric cancer:A meta-analysis of the literature［J］.Tumour Biol,2014,35(5):4849-4858.
[9]Rakhshani N,Kalantari E,Bakhti H,et al.Evaluation of HER-2/neu overexpression in gastric carcinoma using a tissue microarray［J］.Asian Pac J Cancer Prev,2014,15(18):7597-7602.
[10]Chen R,Zhou X,Liu J,et al.Relationship between 18F-FDG PET/CT findings and HER2 expression in gastric cancer［J］.J Nucl Med,2016,57(7):1040-1044.
[11] Blind C,Koepenik A,Pacyna-Gengelbach M,et al.Antigenicity testing by immunohistochemistry after tissue oxidation［J］.J Clin Pathol,2008,61(1):79-83.
[12]Liu Y,Gao JB,Yue SW,et al.A relevant study of MSCT sign and expression of HER2 in gastric cancer［J］.J Pract Radiol,2015,31(3):427-430.［刘洋,高剑波,岳松伟,等.胃癌MSCT表现与HER2基因表达情况的相关性研究［J］.实用放射学杂志,2015,31(3):427-430.］
[13]Zhou F,Li N,Jiang W,et al.Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the To GA clinical trial［J］.World J Surg Oncol,2012,10:274.
[14]Geng Y,Chen X,Qiu J,et al.Human epidermal growth factor receptor-2 expression in primary and metastatic gastric cancer［J］.Int J Clin Oncol,2014,19(2):303-311.
[15]Uprak TK,Attaallah W,Celikel CA,et al.HER-2 incidence in gastric cancer,its association with prognosis and clinicopathological parameters［J］.Ulus Cerrahi Derg,2015,31(4):207-213.

Memo

Memo:
黑龙江省自然科学基金（编号：QC2015110）
Last Update: 2018-01-29